Atlas FDA

INTERSTIM THERAPY SYSTEM FOR URINARY CONTROL

FDA premarket approval P970004/S229 · decided 2016-10-24

Approval details

PMA number
P970004
Supplement
S229
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
INTERSTIM THERAPY SYSTEM FOR URINARY CONTROL
Generic name
Stimulator, electrical, implantable, for incontinence
Applicant
Medtronic Neuromodulation
Date received
2016-09-28
Decision date
2016-10-24
Days to decision
26 days
Decision code
OK30
Product code
EZW
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Minneapolis, MN
Statement
Addition of an inspection for a concentricity requirement to the strain relief part of the InterStim II Model 3058.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SureTune4 Software (DEN210003)Medtronic Neuromodulation2021-08-23